Clinical Trial Update: Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating alanyl-glutamine versus glycine in children with persistent diarrhea or malnutrition has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Malnutrition

Drugs mentioned

• Alanyl-glutamine (alanyl-glutamine)
• Glycine (glycine)

Snippet

Sponsor: University of Virginia | Conditions: Diarrhea, Malnutrition | Phase 3 | Status: WITHDRAWN